# Risk Assessment Document (ISO 14971)

## Document Information
- **Document Title**: Risk Assessment for Nino Medical AI Demo
- **Version**: 1.0
- **Date**: July 13, 2025
- **Document Owner**: [Project Lead]
- **Approved By**: [To be assigned]

## Executive Summary
This document provides a comprehensive risk assessment for the Nino Medical AI Demo project in accordance with ISO 14971:2019 Medical Device Risk Management requirements.

## 1. Project Scope and Intended Use

### 1.1 Intended Use
- **Primary Purpose**: Educational and research tool for medical AI concepts
- **Target Users**: Medical students, researchers, healthcare professionals, AI developers
- **Use Environment**: Educational institutions, research facilities, personal learning
- **Limitations**: NOT for clinical diagnosis or patient care decisions

### 1.2 System Description
- Open-source medical AI demonstration platform
- Uses synthetic data only (no real patient information)
- Implements machine learning models for risk prediction
- Provides educational resources and code examples

## 2. Risk Management Process

### 2.1 Risk Management Team
- **Risk Manager**: [To be assigned]
- **Technical Lead**: [Current technical lead]
- **Clinical Advisor**: [To be assigned]
- **Quality Assurance**: [To be assigned]

### 2.2 Risk Acceptance Criteria
- **Catastrophic (5)**: Unacceptable under any circumstances
- **Critical (4)**: Requires immediate mitigation
- **Moderate (3)**: Acceptable with mitigation measures
- **Minor (2)**: Acceptable with monitoring
- **Negligible (1)**: Acceptable without additional measures

## 3. Hazard Analysis

### 3.1 Identified Hazards

#### H001: Misuse in Clinical Settings
- **Description**: User applies tool for actual patient diagnosis despite warnings
- **Potential Harm**: Incorrect medical decisions, patient harm
- **Severity**: 5 (Catastrophic)
- **Probability**: 2 (Unlikely)
- **Risk Score**: 10 (High)

#### H002: Data Privacy Breach
- **Description**: Unauthorized access to user data or feedback
- **Potential Harm**: Privacy violation, data exposure
- **Severity**: 3 (Moderate)
- **Probability**: 2 (Unlikely)
- **Risk Score**: 6 (Medium)

#### H003: Algorithm Bias
- **Description**: AI models exhibit biased behavior in predictions
- **Potential Harm**: Reinforcement of medical biases, educational misinformation
- **Severity**: 3 (Moderate)
- **Probability**: 3 (Possible)
- **Risk Score**: 9 (High)

#### H004: Software Defects
- **Description**: Bugs or errors in code affect functionality
- **Potential Harm**: Incorrect results, system failure
- **Severity**: 2 (Minor)
- **Probability**: 3 (Possible)
- **Risk Score**: 6 (Medium)

#### H005: Educational Misinformation
- **Description**: Incorrect or misleading educational content
- **Potential Harm**: Poor learning outcomes, knowledge gaps
- **Severity**: 3 (Moderate)
- **Probability**: 2 (Unlikely)
- **Risk Score**: 6 (Medium)

## 4. Risk Control Measures

### 4.1 H001: Misuse in Clinical Settings
**Control Measures:**
- Prominent disclaimers throughout application
- "NOT FOR CLINICAL USE" warnings on all pages
- Educational use only licensing terms
- User acknowledgment requirements

**Verification:**
- Review all user interfaces for disclaimer presence
- Legal review of terms and conditions
- User testing to confirm warning visibility

**Validation:**
- Monitor usage patterns for clinical misuse indicators
- User feedback analysis for inappropriate use cases

### 4.2 H002: Data Privacy Breach
**Control Measures:**
- GDPR-compliant data handling
- Minimal data collection practices
- Secure data storage with access controls
- Regular security audits

**Verification:**
- Privacy impact assessment
- Security penetration testing
- Access control validation

**Validation:**
- Monitor for security incidents
- Regular compliance audits

### 4.3 H003: Algorithm Bias
**Control Measures:**
- Bias testing and validation procedures
- Diverse synthetic data generation
- Algorithm fairness assessments
- Transparent model documentation

**Verification:**
- Statistical bias analysis
- Fairness metric evaluation
- Peer review of algorithms

**Validation:**
- Ongoing monitoring of model outputs
- User feedback on bias concerns

### 4.4 H004: Software Defects
**Control Measures:**
- Comprehensive testing suite
- Code review processes
- Continuous integration/deployment
- Bug tracking and resolution

**Verification:**
- Unit and integration testing
- Code coverage analysis
- Static code analysis

**Validation:**
- User error reporting system
- Performance monitoring
- Regular updates and patches

### 4.5 H005: Educational Misinformation
**Control Measures:**
- Expert content review
- Peer review process
- Clear citations and references
- User feedback mechanisms

**Verification:**
- Subject matter expert validation
- Educational content audits
- Accuracy verification procedures

**Validation:**
- User comprehension testing
- Educational outcome assessment
- Continuous content updates

## 5. Residual Risk Assessment

### 5.1 Post-Mitigation Risk Levels

| Hazard ID | Initial Risk | Post-Mitigation Risk | Status |
|-----------|-------------|---------------------|--------|
| H001      | 10 (High)   | 4 (Low)            | Acceptable |
| H002      | 6 (Medium)  | 3 (Low)            | Acceptable |
| H003      | 9 (High)    | 6 (Medium)         | Acceptable |
| H004      | 6 (Medium)  | 3 (Low)            | Acceptable |
| H005      | 6 (Medium)  | 3 (Low)            | Acceptable |

### 5.2 Risk Acceptability
All residual risks are within acceptable limits for an educational/research tool. The primary risk (clinical misuse) is adequately mitigated through comprehensive warnings and usage restrictions.

## 6. Risk Management Report

### 6.1 Summary
- **Total Hazards Identified**: 5
- **High Risks**: 2 (reduced to acceptable levels)
- **Medium Risks**: 3 (reduced to acceptable levels)
- **Risk Control Measures**: 20 implemented
- **Overall Risk Level**: Acceptable for intended use

### 6.2 Risk Management Activities
- Risk assessment completed: July 13, 2025
- Control measures implemented: Ongoing
- Verification activities: Planned
- Validation activities: Planned
- Post-market surveillance: Planned

### 6.3 Risk Management File
This document serves as the main risk management file for the project. All risk-related documentation will be maintained and updated as the project evolves.

## 7. Post-Market Surveillance

### 7.1 Monitoring Activities
- User feedback collection and analysis
- Error reporting and tracking
- Usage pattern monitoring
- Security incident monitoring

### 7.2 Review Schedule
- Monthly risk review meetings
- Quarterly risk assessment updates
- Annual comprehensive risk review
- Ad-hoc reviews for significant changes

## 8. Approval and Review

### 8.1 Document Approval
- **Prepared By**: [Risk Manager]
- **Reviewed By**: [Technical Lead]
- **Approved By**: [Project Lead]
- **Date**: July 13, 2025

### 8.2 Next Review Date
- **Scheduled Review**: October 13, 2025
- **Review Frequency**: Quarterly
- **Update Triggers**: System changes, new hazards, regulatory changes

---

**Document Control**
- Version: 1.0
- Classification: Internal
- Distribution: Risk Management Team, Project Stakeholders
- Retention: 7 years from project completion
